Novavax, Inc. (NVAX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.05 -1.11%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $7.5 million, versus $3.8 million reported last year.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
